Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Synaptogenix (SNPX)
NASDAQ:SNPX
Synaptogenix (SNPX) Stock Price & Analysis
33 Followers
SNPX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.70 - $8.75
Previous Close$0.85
Volume11.92K
Average Volume (3M)60.12K
Market Cap
$6.26M
Enterprise Value-$29.54M
Total Cash (Recent Filing)$35.80M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.4
Beta1.57
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.60
Shares Outstanding7,359,871
10 Day Avg. Volume89,200
30 Day Avg. Volume60,118
Standard Deviation0.28
R-Squared0.09
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.21
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda6.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Synaptogenix News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SNPX FAQ
What was Synaptogenix’s price range in the past 12 months?
Synaptogenix lowest stock price was $0.70 and its highest was $8.75 in the past 12 months.
What is Synaptogenix’s market cap?
Currently, no data Available
When is Synaptogenix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Synaptogenix’s earnings last quarter?
Currently, no data Available
Is Synaptogenix overvalued?
According to Wall Street analysts Synaptogenix’s price is currently Overvalued.
Does Synaptogenix pay dividends?
Synaptogenix does not currently pay dividends.
What is Synaptogenix’s EPS estimate?
Synaptogenix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Synaptogenix have?
Synaptogenix has 7,359,871 shares outstanding.
What happened to Synaptogenix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Synaptogenix?
Currently, no hedge funds are holding shares in SNPX
---
Synaptogenix Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.50%
12-Months-Change
Fundamentals
Return on Equity
-12.69%
Trailing 12-Months
Asset Growth
12.91%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Synaptogenix
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
---
Top 5 ETFs holding SNPX
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold SNPX. The ETFs are listed according to market value of SNPX within the ETF
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
Dyadic International
―
TScan Therapeutics
―
Apexigen
―
Moleculin Biotech
―
Jounce Therapeutics
―
---